Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
Yu
Yu
Y
Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales 2006, Australia.
Kalinowski
Danuta S
DS
Kovacevic
Zaklina
Z
Siafakas
Aritee R
AR
Jansson
Patric J
PJ
Stefani
Christian
C
Lovejoy
David B
DB
Sharpe
Philip C
PC
Bernhardt
Paul V
PV
Richardson
Des R
DR
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000737:chemistry / Q000378:metabolism; D007502:Iron Chelating Agents / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D013882:Thiosemicarbazones / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007502:Iron Chelating Agents; D013882:Thiosemicarbazones; D007501:Iron; D012264:Ribonucleotide Reductases